spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  macular degeneration, 

 HSMN NewsFeed - 24 Jul 2024
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 21 May 2024
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili(TM). Enters U.S. Ophthalmology Market
Biopharmaceuticals Generics Ophthalmology FDA
 HSMN NewsFeed - 3 Jul 2023
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
Regenerative Medicine Ophthalmology FDA
 HSMN NewsFeed - 5 Jan 2023
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 21 Oct 2022
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 8 Aug 2022
Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 Jul 2022
Carl Zeiss Meditec and Precise Bio Announce Partnership in the Development and Commercialization of Tissue-Based Implants for Ophthalmology
Regenerative Medicine Ophthalmology
 HSMN NewsFeed - 29 Jun 2022
EYLEA(R) (aflibercept) Injection sBLA for Every 16-week Dosing Regimen in Patients with Diabetic Retinopathy Accepted for FDA Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Mar 2022
LumiThera, Inc. Announces Completion of Diopsys, Inc. Acquisition
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 25 Jan 2022
Nanoscope Therapeutics Announces FDA Clearance of IND for MCO-010 Gene Therapy in Stargardt Macular Degeneration Patients
Regenerative Medicine Ophthalmology FDA
 HSMN NewsFeed - 11 Nov 2021
LumiThera, Inc. Announces Creation of a Light-based Theranostic Approach to Treat Ocular Disease with Acquisition of Diopsys, Inc.
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 13 Sep 2021
AbbVie and REGENXBIO Announce Eye Care Collaboration
Biopharmaceuticals Regenerative Medicine Ophthalmology
 HSMN NewsFeed - 7 May 2021
LumiThera Presents Valeda Treatment Benefits for Photobiomodulation in Early Patients with Diabetic Retinopathy and Macular Edema
Devices Ophthalmology
 HSMN NewsFeed - 7 Apr 2021
LumiThera Announces Top Line Data in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration
Devices Ophthalmology
 HSMN NewsFeed - 17 Jul 2020
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement in Patients Living with X-Linked Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 13 Sep 2018
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 17 Aug 2018
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 13 Aug 2018
Regeneron Provides Regulatory Update on EYLEA(R) (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 24 Apr 2018
Lin BioScience Announces FDA Orphan Drug Designation for LBS-007 for the Treatment of Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Apr 2018
FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care
Devices Ophthalmology FDA Product Launch
 HSMN NewsFeed - 31 Oct 2017
LumiThera Closes Series B Round of Financing
Devices Ophthalmology Venture Capital Personnel
 HSMN NewsFeed - 3 Jan 2017
Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 1 Dec 2016
Exonate Closes Successful Funding Round - To Develop Eye Drops Treatment for Wet Age-related Macular Degeneration (Wet AMD)
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 2 Aug 2016
pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis
Devices Drug Delivery Orthopaedic
 HSMN NewsFeed - 28 Jun 2016
iSTAR Medical Strengthens Board With Two Senior Appointments
Devices Ophthalmology Personnel
 HSMN NewsFeed - 30 Oct 2015
Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 21 Oct 2015
Allegro Ophthalmics Names Scott Cooper as Chief Financial Officer and Vice President of Business Development and Mohamed Genead, MD, as Executive Medical Director
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 4 Aug 2014
RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2014
RestorGenex Announces Management Changes
Biopharmaceuticals Dermatology Ophthalmology Personnel
 HSMN NewsFeed - 23 Apr 2014
Kala Pharmaceuticals Announces $22.5 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 22 Jan 2014
Advanced Cell Technology Announces Change in Management
Regenerative Medicine Ophthalmology Personnel
 HSMN NewsFeed - 17 Jan 2014
Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene(TM) AMD test in North America
Diagnostics Ophthalmology Licensing
 HSMN NewsFeed - 18 Dec 2013
Regeneron Announces FDA Acceptance of EYLEA(R) (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Regenerative Medicine Personnel
 HSMN NewsFeed - 25 Nov 2013
Pixium Vision raises €15 million led by Sofinnova Partners
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 22 Nov 2013
EYLEA(R) (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 12 Nov 2013
Bayer receives approval for Eylea(R) as new drug to treat wet Age-Related Macular Degeneration Patients in Canada
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 6 Aug 2013
James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
Biopharmaceuticals Drug Delivery Ophthalmology Personnel
 HSMN NewsFeed - 26 Jul 2013
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion in Europe
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 29 May 2013
Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista(TM) Anti-PDGF Combination Therapy in Wet AMD
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 22 May 2013
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2013
New Therapy for Wet AMD Introduced in Switzerland by Oraya(R) Therapeutics and EyeRAD
Devices Ophthalmology
 HSMN NewsFeed - 11 Mar 2013
MacuLogix Raises $3.6 Million in Series A Round
Diagnostics Ophthalmology Venture Capital
 HSMN NewsFeed - 19 Feb 2013
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 6 Dec 2012
EYLEA(R) (aflibercept) Submitted for EU Marketing Authorization for the Treatment of Macular Edema Following Central Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 27 Nov 2012
EYLEA(R) (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Europe
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 14 May 2012
FDA Grants Fast Track Designation to Ohr Pharmaceutical's Squalamine Eye Drops for the Treatment of Wet-AMD
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 3 May 2012
Oraya Therapeutics Achieves Successful INTREPID Study Outcomes with a Non-Invasive Radiation Therapy for Wet AMD
Devices Ophthalmology
 HSMN NewsFeed - 2 May 2012
ACT Announces Massachusetts Eye and Ear as Additional Site for Clinical Trial for Dry Age-Related Macular Degeneration Using Human Embryonic Stem Cell-Derived RPE Cells
Regenerative Medicine Ophthalmology
 HSMN NewsFeed - 19 Apr 2012
RetroSense Welcomes Dr. Peter Francis as Clinical Director
Regenerative Medicine Ophthalmology Personnel
 HSMN NewsFeed - 8 Mar 2012
Regeneron and Bayer Announce Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 3 Jan 2012
New Study Links Daily Aspirin Use to Increased Risk of Age-Related Macular Degeneration
Biopharmaceuticals Cardiology Ophthalmology
 HSMN NewsFeed - 6 Jun 2011
ZALTRAP (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Apr 2011
FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 19 Jul 2010
NovaVision's FDA-Cleared Visual Restoration Therapy (VRT) System and Company Assets Now Available
Devices
 HSMN NewsFeed - 22 Jun 2010
QLT Announces Final Results From Its RADICAL Study Evaluating Verteporfin PDT (Visudyne(R)) Combination Therapy in Exudative AMD
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 7 Apr 2010
Oraya Therapeutics Granted European CE Mark for the IRay(TM) Stereotactic Radiotherapy System
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 6 Apr 2010
IMI Intelligent Medical Implants Names Robert J. Rosenthal Chief Executive Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 16 Mar 2010
Promedior Closes $12 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Feb 2010
OXiGENE Announces Restructuring to Focus Resources on Key Programs and Provides Business Update
Biopharmaceuticals
 HSMN NewsFeed - 15 Dec 2009
Ophthotech Raises $30 Million in Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 20 Jul 2009
Oraya Therapeutics Raises $42 Million in Series C Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 26 May 2009
Ophthonix Completes Series AA Financing at $25.9 Million
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Dec 2008
Catalyst Biosciences Raises $40 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Oct 2008
OXiGENE, Inc. Names John A. Kollins as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Aug 2008
Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration
Biopharmaceuticals Opthalmology
 HSMN NewsFeed - 9 Jul 2008
Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Oral Zinthionein for Dry Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 23 Jun 2008
EyeCyte, Inc. Secures Series A Funding from Pfizer
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 28 Mar 2008
Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 1 Feb 2008
Taligen Therapeutics Secures Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jan 2008
Biogen Idec and PDL BioPharma License the Rights to Develop Volociximab in Ophthalmic Indications to Ophthotech
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 31 Dec 2007
OXiGENE Reports Positive Results in Phase 2 Study of ZYBRESTAT(TM) in Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Nov 2007
First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 9 Oct 2007
Optherion, Inc. Completes $37 Million Start Up Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 24 Sep 2007
Alcon Receives FDA Decision on RETAANE(R) Suspension for Wet AMD
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 4 Sep 2007
Quark Pharmaceuticals Appoints New Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2007
TargeGen, Inc. Closes $40M Series 'D' Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Jul 2007
Pipex Pharmaceuticals Acquires Late-Stage Oral Candidate for Dry Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 9 May 2007
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 9 Apr 2007
Sirion Therapeutics Completes $45 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 19 Jan 2007
Bioptigen Receives FDA Clearance and Two Phase II SBIR Awards; Company to Exhibit at Major Technology Conference
Devices Ophthalmology
 HSMN NewsFeed - 3 Jan 2007
Genaera Corporation Terminates EVIZON(TM) Clinical Program and Restructures
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 14 Dec 2006
Ophthonix Completes Series D Financing at $35.1 Million
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 11 Nov 2006
OptiMedica Launches Suite of Integrated Practice Solutions for the Pascal Photocoagulator
Devices Ophthalmology
 HSMN NewsFeed - 9 Nov 2006
Genentech Announces Agreement to Acquire Tanox for $20 Per Share
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Nov 2006
Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2007
Devices Biopharmaceuticals Cardiology Oncology Neurology
 HSMN NewsFeed - 20 Oct 2006
FDA Approves Prescription Zaditor(R) for Over-The-Counter Relief From Itchy Eyes
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 25 Sep 2006
OptiMedica Announces Clinical Outcomes of 1,200 Patients Treated with PASCAL Method of Photocoagulation
Devices Ophthalmology
 HSMN NewsFeed - 18 Sep 2006
Sirion Therapeutics, Inc. Combines With Tenby Pharma Inc.
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 9 Sep 2006
OptiMedica Receives ISO Certification and CE Mark for the PASCAL(R) Photocoagulator
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 26 Jun 2006
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Devices Ophthalmology Licensing
 HSMN NewsFeed - 2 Jun 2006
Preliminary Results from a Phase IIIb Study Showed Patients With Wet AMD Treated With Lucentis Quarterly Experienced a 16-Letter Benefit Over the Control Group at One Year
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 4 May 2006
OSI Pharmaceuticals Summarizes Macugen(R) (pegaptanib sodium injection) Data Presented at Association for Research in Vision and Ophthalmology (ARVO) Meeting
Biopharmaceuticals Ophthalmology
Return to NewsFeed  

 Additional items found! 75

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 75 additional stories matching:
macular degeneration,
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.